Floatz logo

Gtx-006

Prostatic Intraepithelial Neoplasia

GTxPhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Prostatic Intraepithelial Neoplasia cohort.

Asset / SponsorPhaseRating
Flutamide
Ente Ospedaliero Ospedali Galliera
Phase 2/3B
Finasteride
Ente Ospedaliero Ospedali Galliera
Phase 2/3B
9-valent human papillomavirus recombinant vaccine
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3B

Same molecule, other indications

Gtx-006 is also rated in:

invasive breast carcinomaDormant
BB
Indicative ·
65 / 100
View asset →
Her2-receptor negative breast cancerDormant
BB
Indicative ·
65 / 100
View asset →
breast carcinoma in situDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →